These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 506780)

  • 1. [Analysis of dependence of pharmacological activity of new pyrimidine compounds on their chemical structure. I. General pharmacological properties].
    Oledzka K
    Acta Pol Pharm; 1979; 36(1):95-102. PubMed ID: 506780
    [No Abstract]   [Full Text] [Related]  

  • 2. [Leukotrienes and the cardiovascular system].
    Sagach VF
    Patol Fiziol Eksp Ter; 1986; (1):84-9. PubMed ID: 3010220
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of relaxant effects of trapidil in isolated dog coronary artery.
    Sakanashi M; Yoshikawa Y; Kondoh G; Fukai R; Hirata A; Higuchi M
    Arzneimittelforschung; 1980; 30(11):1871-4. PubMed ID: 7192995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thromboxane A2 antagonistic effect of antiangina drugs, with special reference to trapidil and trapidil derivatives].
    Mentz P; Pawelsky KE; Giessler C; Mest HJ
    Pharmazie; 1987 Sep; 42(9):613-6. PubMed ID: 3432348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of certain new 2,4,5(6) trisubstituted-1,2,4-triazolo[1,5-alpha]pyrimidines as potential antihypertensive agents.
    Bayomi SM; Abdelal AM; el-Ashry SM; Ghoneim OA
    Boll Chim Farm; 1999 May; 138(5):227-32. PubMed ID: 10450124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological activity of 2-alkylthio substituted thieno[2,3-d]pyrimidine-4-one and 5H-pyrimido [5,4-b]indol-4-one.
    Russo F; Santagati NA; Venturini R; Spampinato S
    Pharmazie; 1990 Jul; 45(7):493-5. PubMed ID: 2236192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitussive activity and other related pharmacological properties of d-3-methyl-N-methylmorphinan (AT-17).
    Kasé Y; Kito G; Miyata T; Uno T; Takahama K; Ida H
    Arzneimittelforschung; 1976; 26(3):353-60. PubMed ID: 989326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening pharmacological studies of four dihydroisoquinoline derivatives.
    Stoychev T; Koleva M; Orahovats A; Trifonov L
    Acta Physiol Pharmacol Bulg; 1979; 5(3):82-90. PubMed ID: 539451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of alkyl substitution in drugs. XX. Some pharmacological investigations into a series of 1-(o-alkylphenyl)-2-methyl and 1-(o-alkylphenyl)-2-ethylcyclohexanols.
    Timmerman H; Mulder D; Nauta WT
    Arzneimittelforschung; 1969 Aug; 19(8):1254-7. PubMed ID: 4390181
    [No Abstract]   [Full Text] [Related]  

  • 10. Some observations on the pharmacological effects of salbutamol, with particular reference to the cardiovascular system.
    Nayler WG
    Postgrad Med J; 1971 Mar; 47():Suppl:16-21. PubMed ID: 5572512
    [No Abstract]   [Full Text] [Related]  

  • 11. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Difference of tolerances to isoprenaline between tracheal and vascular smooth muscles and cardiac conduction system in guinea pigs].
    Zhao SJ; Sun GL; Cao YS
    Zhongguo Yao Li Xue Bao; 1990 May; 11(3):210-3. PubMed ID: 1965090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxins.
    Simpson LL
    J Pharmacol Exp Ther; 1982 Dec; 223(3):695-701. PubMed ID: 6292397
    [No Abstract]   [Full Text] [Related]  

  • 14. [4-[Benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds with selective antagonistic activity against H1-histamine receptors].
    Mossini F; Maggiali C; Morini G; Impicciatore M; Morini G; Molina E
    Farmaco Sci; 1984 Mar; 39(3):189-99. PubMed ID: 6143687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiology of the coronary circulation as a basis for evaluation of coronary dilators].
    Lochner W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):127-44. PubMed ID: 4979631
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationship between pharmacological effect and chemical structure of new pyrimidine derivatives. II. Effect on various hemodynamic and biochemical parameters].
    Oledzka K
    Acta Pol Pharm; 1979; 36(2):251-8. PubMed ID: 532681
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.